Healthcare information provider Wolters Kluwer Health has announced that Lexicomp® Online™, its hospital-wide referential drug information solution, now includes its industry-leading Facts & Comparisons® Off-Label database and VisualDx® drug eruption content. The enhancements are part of an ongoing integration of Wolters Kluwer Clinical Drug Information solutions to deliver to clinicians extensive medication decision support at the point of care.
The Facts & Comparisons Off-Label database provides information on more than 1,200 off-label medication uses, therapy statements, and evidence ratings, enhancing patient safety and providing valuable context. Users can also access nearly 350 in-depth off-label monographs including dosing studies and risk/benefits discussion for more informed decision-making. Availability of off-label indication information helps improve efficiencies by providing a summary statement of uses within core drug content while also enabling more in-depth research with intuitive access to a deeper level of information to support treatment recommendations and clinician education.
Also newly integrated with Lexicomp Online is industry-leading VisualDx drug eruption content to help clinicians identify drug-induced conditions of the skin. Offered by Logical Images, VisualDx is recognized as the premier solution that aids clinicians in the identification of a variety of skin lesions. By entering visual and other cues, such as lesion type, clinicians can quickly and easily confirm skin reactions and link directly to drug eruption content within Lexicomp drug monographs in the Warnings and Precautions fields. This integration also helps clinicians identify appropriate ICD-9 and ICD-10 codes and provides additional related information, such as supportive patient care and therapy options.
